<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Behav</journal-id><journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id><journal-id journal-id-type="publisher-id">BRB3</journal-id><journal-title-group><journal-title>Brain and Behavior</journal-title></journal-title-group><issn pub-type="epub">2162-3279</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27247854</article-id><article-id pub-id-type="pmc">4864053</article-id><article-id pub-id-type="doi">10.1002/brb3.484</article-id><article-id pub-id-type="publisher-id">BRB3484</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Exogenous dopamine reduces <styled-content style="fixed-case">GABA</styled-content> receptor availability in the human brain</article-title><alt-title alt-title-type="left-running-head">H. C. Lou <italic>et&#x000a0;al</italic>.</alt-title></title-group><contrib-group><contrib id="brb3484-cr-0001" contrib-type="author" corresp="yes"><name><surname>Lou</surname><given-names>Hans C.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0002" contrib-type="author"><name><surname>Rosenstand</surname><given-names>Astrid</given-names></name><xref ref-type="aff" rid="brb3484-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="brb3484-cr-0003" contrib-type="author"><name><surname>Brooks</surname><given-names>David J.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0004" contrib-type="author"><name><surname>Bender</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0005" contrib-type="author"><name><surname>Jakobsen</surname><given-names>Steen</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0006" contrib-type="author"><name><surname>Blicher</surname><given-names>Jakob U.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0007" contrib-type="author"><name><surname>Hansen</surname><given-names>Kim V.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0008" contrib-type="author"><name><surname>M&#x000f8;ller</surname><given-names>Arne</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="brb3484-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">CFIN and Pet Center</named-content><institution>Aarhus University</institution><named-content content-type="street">Norregade 44</named-content><named-content content-type="post-code">8000</named-content><named-content content-type="city">Aarhus</named-content><country country="DK">Denmark</country></aff><aff id="brb3484-aff-0002"><label><sup>2</sup></label><institution>Dept. Ophtalmology</institution><institution>Rigshospitalet</institution><institution>Glostrup</institution><institution>Copenhagen University</institution><country country="DK">Denmark</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Hans C. Lou, CFIN, Aarhus University, Norregade 44, 8000 Aarhus, Denmark. Tel: +4545811476; Fax: 78464400; E&#x02010;mail: <email>hanslou1@gmail.com</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2016</year></pub-date><volume>6</volume><issue>7</issue><issue-id pub-id-type="doi">10.1002/brb3.2016.6.issue-7</issue-id><elocation-id>e00484</elocation-id><history><date date-type="received"><day>13</day><month>11</month><year>2015</year></date><date date-type="rev-recd"><day>10</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2016 Published by Wiley Periodicals, Inc. <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2016 The Authors. <italic>Brain and Behavior</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BRB3-6-e00484.pdf"/><abstract id="brb3484-abs-0001"><title>Abstract</title><sec id="brb3484-sec-0001"><title>Background</title><p>While it has recently been shown that dopamine release stimulates conscious self&#x02010;monitoring through the generation of gamma oscillations in medial prefrontal/anterior cingulate cortex, and that the <styled-content style="fixed-case">GABA</styled-content>ergic system is effective in producing such oscillations, interaction of the two transmitter systems has not been demonstrated in humans. We here hypothesize that dopamine challenge stimulates the <styled-content style="fixed-case">GABA</styled-content> system directly in the medial prefrontal/anterior cingulate region in the human brain.</p></sec><sec id="brb3484-sec-0002"><title>Methods</title><p>Positron emission tomography (<styled-content style="fixed-case">PET</styled-content>) with the <styled-content style="fixed-case">GABA</styled-content> receptor <italic>&#x003b1;</italic>1/<italic>&#x003b1;</italic>5 subtype ligand [<sup>11</sup>C] Ro15&#x02010;4513 was used to detect changes in <styled-content style="fixed-case">GABA</styled-content> receptor availability after clinical oral doses of levodopa in a double blind controlled study.</p></sec><sec id="brb3484-sec-0003"><title>Results</title><p>We here provide the first direct evidence for such coupling in the cerebral cortex, in particular in the medial prefrontal anterior cingulate region, by showing that exogenous dopamine decreases [<sup>11</sup>C] Ro15&#x02010;4513 binding widely in the human brain compatible with a fall in <italic>&#x003b1;</italic>1 subtype availability in <styled-content style="fixed-case">GABA</styled-content> complexes due to increased <styled-content style="fixed-case">GABA</styled-content> activity.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="brb3484-kwd-0001">Dopamine</kwd><kwd id="brb3484-kwd-0002"><styled-content style="fixed-case">GABA</styled-content></kwd><kwd id="brb3484-kwd-0003">insula</kwd><kwd id="brb3484-kwd-0004">medial prefrontal/anterior cingulate</kwd><kwd id="brb3484-kwd-0005">self&#x02010;awareness</kwd></kwd-group><funding-group><award-group><funding-source>Danish Research Council</funding-source><award-id>DFF&#x02010;1317&#x02010;00010</award-id></award-group></funding-group><counts><page-count count="5"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>brb3484</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.2 mode:remove_FC converted:20.07.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="brb3484-cit-1001">
<string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Brooks</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Bender</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jakobsen</surname>
</string-name>, <string-name>
<given-names>J. U.</given-names>
<surname>Blicher</surname>
</string-name>, <string-name>
<given-names>K. V.</given-names>
<surname>Hansen</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>M&#x000f8;ller</surname>
</string-name>, <article-title>Exogenous dopamine reduces GABA receptor availability in the human brain</article-title>, <source>Brain and Behavior</source>, <year>2016</year>; <volume>6</volume>(<issue>7</issue>), e00484, doi: <ext-link ext-link-type="doi" xlink:href="10.1002/brb3.484">10.1002/brb3.484</ext-link>
</mixed-citation>
</p></notes></front><body><sec id="brb3484-sec-0004"><title>Introduction</title><p>Cognition depends on paralimbic medial prefrontal/anterior cingulate and medial parietal hubs (Lou et&#x000a0;al. <xref rid="brb3484-bib-0013" ref-type="ref">2004</xref>; Luber et&#x000a0;al. <xref rid="brb3484-bib-0015" ref-type="ref">2012</xref>) and their rich network of highly oxygen&#x02010;demanding, fast&#x02010;spiking GABAergic interneurons (Tomasi et&#x000a0;al. <xref rid="brb3484-bib-0023" ref-type="ref">2013</xref>). The network is regulated by dopamine, which in humans stimulates medial prefrontal/anterior cingulate cortex and insula, thereby generating gamma oscillations (Joensson et&#x000a0;al. <xref rid="brb3484-bib-0008" ref-type="ref">2015</xref>) essential for cognitive function (Voss et&#x000a0;al. <xref rid="brb3484-bib-0024" ref-type="ref">2014</xref>). The high oxygen requirement of these hubs (Tomasi et&#x000a0;al. <xref rid="brb3484-bib-0023" ref-type="ref">2013</xref>) makes the system vulnerable in penuria, and dysfunction is associated with disorders like ADHD (Castellanos et&#x000a0;al. <xref rid="brb3484-bib-0002" ref-type="ref">2008</xref>), autistic spectrum disorder (Assaf et&#x000a0;al. <xref rid="brb3484-bib-0001" ref-type="ref">2010</xref>), schizophrenia (Gallinat et&#x000a0;al. <xref rid="brb3484-bib-0004" ref-type="ref">2004</xref>), addiction (Romer et&#x000a0;al. <xref rid="brb3484-bib-0017" ref-type="ref">2013</xref>), and dementia (Liu et&#x000a0;al. <xref rid="brb3484-bib-0012" ref-type="ref">2014</xref>), and can follow traumatic brain injury (Ham et&#x000a0;al. <xref rid="brb3484-bib-0006" ref-type="ref">2014</xref>). It is, therefore, important to determine how the information gathered in animal models on the molecular arrangement of dopamine/GABA interaction (Sesack et&#x000a0;al. <xref rid="brb3484-bib-0020" ref-type="ref">2003</xref>) translates into the human brain. This is particularly the case for the medial prefrontal/anterior cingulate region which facilitates attention and self&#x02010;awareness. With that aim we here examined the effect of oral <sc>l</sc>&#x02010;dopa, a dopamine prodrug, on the activation of the GABA system in the human living cerebral cortex. The idea that dopamine release regulates cognition, including conscious experience, via the GABAergic system is based on the finding that dopamine increases confidence and accuracy of seeing rapidly presented words (Lou et&#x000a0;al. <xref rid="brb3484-bib-0014" ref-type="ref">2011</xref>), and on the fact that GABAergic interneurons are instrumental in mediating cognition in rodents (Sohal et&#x000a0;al. <xref rid="brb3484-bib-0021" ref-type="ref">2009</xref>). The hypothesis is further strengthened by the recent demonstration that dopamine release in the medial prefrontal/anterior cingulate cortex activates self&#x02010;monitoring and metacognition (Joensson et&#x000a0;al. <xref rid="brb3484-bib-0008" ref-type="ref">2015</xref>). Theoretical aspects of interaction between dopamine and GABA function have been studied in detail in a recent neurocomputational model by Lew and Tseng (<xref rid="brb3484-bib-0010" ref-type="ref">2014</xref>).</p><p>Direct experimental approaches have been scarce, but recently it has been demonstrated that extracellular striatal dopamine elicits opposing effects on the GABA system in rodents: dopamine release <italic>activates</italic> synaptically located GABA<sub>A</sub> receptor subtypes, including alpha 5, but <italic>inhibits</italic> tonic GABA<sub>A</sub> currents via extrasynaptically located tonic level GABA<sub>A</sub> receptors (Hoerbelt et&#x000a0;al. <xref rid="brb3484-bib-0007" ref-type="ref">2015</xref>). These effects of dopamine mimic similar opposing effects of extracellular GABA (Ransom et&#x000a0;al. <xref rid="brb3484-bib-0016" ref-type="ref">2013</xref>), and are in accordance with the concept that tonic GABA currents are a homeostatic regulator responding to localized synaptic stimulation of GABA receptors by decreasing excitability in the network (Stokes et&#x000a0;al. <xref rid="brb3484-bib-0022" ref-type="ref">2014</xref>). Here, we provide the first direct in&#x000a0;vivo evidence for such interaction in humans by showing that an exogenous dopamine challenge in physiological relevant dosage decreases GABA receptor availability, reflecting increased GABA activity.</p></sec><sec id="brb3484-sec-0005"><title>Participants and Procedures</title><p>The study was approved by the local ethical board (Region Midtjylland). After information given orally and in writing, and consent, nine healthy males were studied. This provides 80% power to detect a 20% reduction of anterior cingulate Ro 15&#x02010;4513 binding at <italic>P</italic>&#x000a0;=&#x000a0;0.05. The participants were without current medication. None had a history of mental or neurological disorders, or a history of addiction, with the exception that two had been smokers 10 and 15&#x000a0;years ago, respectively. Median age was 29&#x000a0;years, range 24&#x02013;47. The PET ligand [<sup>11</sup>C]Ro15&#x02010;4513 is sensitive to interstitial GABA levels evidenced as a fall in availability of <italic>&#x003b1;</italic>1 subtype sites on the GABA complex for its binding (Semyano et&#x000a0;al. <xref rid="brb3484-bib-0019" ref-type="ref">2004</xref>; Stokes et&#x000a0;al. <xref rid="brb3484-bib-0022" ref-type="ref">2014</xref>). While [<sup>11</sup>C]Ro15&#x02010;4513 binds to both the <italic>&#x003b1;</italic>1 and <italic>&#x003b1;</italic>5 receptor subtypes, the <italic>&#x003b1;</italic>1 subtype is present at a greater density and increases in brain GABA have been shown to reduce its availability, while <italic>&#x003b1;</italic>5 binding site availability is either unaffected or mildly elevated. In the present study, it was not possible to separate signals from <italic>&#x003b1;</italic>1 and <italic>&#x003b1;</italic>5 subunits of the GABA complex as we did not have an arterial input curve so we have assumed that any decreased Ro 15&#x02010;4513 binding seen represented competitive occupancy of <italic>&#x003b1;</italic>1 sites by endogenous GABA (Lingford&#x02010;Hughes et&#x000a0;al. <xref rid="brb3484-bib-0011" ref-type="ref">2002</xref>).</p><p>Each participant was studied twice in counterbalanced order with an interval of at least several days. We used PET following an oral <sc>l</sc>&#x02010;dopa/dopamine challenge or placebo in identical capsules given orally containing either sinemet (MSD, 100&#x000a0;mg <sc>l</sc>&#x02010;dopa plus 25&#x000a0;mg carbidopa) or placebo (starch). The medication was unknown to the participants and experimenters responsible for PET injection and calculation of binding potentials. The administration of <sc>l</sc>&#x02010;dopa or placebo was done between 30 and 45&#x000a0;min prior to intravenous injection of [<sup>11</sup>C]Ro15&#x02010;4513. This interval is based on the interval for obtaining peak plasma concentrations and clinical effects on parkinsonism after oral sinemet medication (Joensson et&#x000a0;al. <xref rid="brb3484-bib-0008" ref-type="ref">2015</xref>).</p></sec><sec id="brb3484-sec-0006"><title>Results and Discussion</title><p>The distribution of [<sup>11</sup>C]Ro15&#x02010;4513 binding with placebo is shown in Figure&#x000a0;<xref rid="brb3484-fig-0001" ref-type="fig">1</xref>. After placebo administration, the ligand is bound primarily in medial prefrontal/anterior cingulate cortex and left and right insula. The cerebellum provides a reference for nonspecific tissue binding of the tracer. After <sc>l</sc>&#x02010;dopa, [<sup>11</sup>C]Ro15&#x02010;4513 binding is reduced, which can be seen more clearly by subtraction. There is a reduction of between 5% and 20% throughout most of gray matter regions (BP 100x [placebo minus dopamine]/placebo). Small foci of BP <italic>increases</italic> were, however, present in the hippocampi, possibly reflecting the high concentration of D4 dopamine receptors there which inhibit interneuron GABA release when activated (Romo&#x02010;Parra et&#x000a0;al. <xref rid="brb3484-bib-0018" ref-type="ref">2005</xref>).</p><fig fig-type="Figure" xml:lang="en" id="brb3484-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Distribution of [<sup>11</sup>C]Ro15&#x02010;4513. After placebo, the ligand was bound primarily in medial prefrontal/anterior cingulate cortex and left and right insula. After dopamine challenge ligand binding is reduced. This is seen more clearly by subtraction, with a general reduction of between 5% and 20% throughout gray matter (<styled-content style="fixed-case">BP</styled-content> 100x [placebo minus dopamine]/placebo). In the hippocampal regions there were small foci of increased <styled-content style="fixed-case">BP</styled-content>.</p></caption><graphic id="nlm-graphic-3" xlink:href="BRB3-6-e00484-g001"/></fig><p>Quantification using parametric modeling is shown in Figure&#x000a0;<xref rid="brb3484-fig-0002" ref-type="fig">2</xref> for medial prefrontal/anterior cingulate region, left and right insula, cerebellum, and whole gray matter. For a composite gray matter region, a one&#x02010;sample <italic>t</italic>&#x02010;test showed that <sc>l</sc>&#x02010;dopa was associated with an 11% mean decrease in [<sup>11</sup>C]Ro15&#x02010;4513 BP (<italic>t</italic>&#x000a0;=&#x000a0;&#x02212;2.29, 9 degrees of freedom, <italic>P</italic>&#x000a0;=&#x000a0;0.048). There was a highly significant effect of regions (linear mixed model, <italic>P</italic>&#x000a0;=&#x000a0;0.000049). Because dopamine has previously been shown to stimulate electromagnetic activity and self&#x02010;awareness mainly in the medial prefrontal/anterior cingulate and insula regions (Joensson et&#x000a0;al. <xref rid="brb3484-bib-0008" ref-type="ref">2015</xref>), we a priori calculated BP changes in these regions separately and compared these with cerebellum and whole gray matter, using two&#x02010;tailed <italic>t</italic> tests with Bonferroni corrections and a cut off at <italic>P</italic>&#x000a0;=&#x000a0;0.01. The BP of the GABA ligand decreased significantly with <sc>l</sc>&#x02010;dopa in the medial prefrontal/anterior cingulate and right insula regions (by 18%, <italic>t</italic>&#x000a0;=&#x000a0;&#x02212;3.63 <italic>P</italic>&#x000a0;=&#x000a0;0.0054, and 18%, <italic>t</italic>&#x000a0;=&#x000a0;3.85 <italic>P</italic>&#x000a0;=&#x000a0;0039, respectively), with no significant effect in the other regions.</p><fig fig-type="Figure" xml:lang="en" id="brb3484-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Quantification in medial prefrontal/anterior cingulate region, left and right insula, cerebellum, and whole gray matter. Using parametric modeling, a decrease in [<sup>11</sup>C]Ro15&#x02010;4513 <styled-content style="fixed-case">BP</styled-content> is apparent overall after <sc>l</sc>&#x02010;dopa, except in cerebellum. For statistics, see text.</p></caption><graphic id="nlm-graphic-5" xlink:href="BRB3-6-e00484-g002"/></fig><p>Thus, the main findings were (1) preferential binding of [<sup>11</sup>C]Ro15&#x02010;4513 to <italic>&#x003b1;</italic>1/<italic>&#x003b1;</italic>5 subunits on GABA complexes in the medial prefrontal/anterior cingulate region and (2) a widespread and proportional dopamine&#x02010;induced decrease in binding potentials for the GABA ligand [<sup>11</sup>C]Ro15&#x02010;4513 (Lingford&#x02010;Hughes et&#x000a0;al. <xref rid="brb3484-bib-0011" ref-type="ref">2002</xref>).</p><p>The present results account for the effect of dopamine in its regulation of self&#x02010;awareness via direct action on the GABA system in the medial prefrontal/anterior cingulate cortex. Similarly, the direct effect of dopamine on GABA in right insula, rather than the left, may explain the preferential role of right hemisphere in self&#x02010;recognition (Keenan et&#x000a0;al. <xref rid="brb3484-bib-0009" ref-type="ref">2001</xref>). The close cortical interaction of the two transmitter systems broadens the scope for pharmacological intervention in the many human disorders where the medial prefrontal region is dysfunctional. It may open new perspectives for treatment.</p></sec><sec id="brb3484-sec-0007"><title>Methods</title><sec id="brb3484-sec-0008"><title>Magnetic resonance imaging</title><p>All participants were scanned with a 3T MR system pre&#x02010;registration with PET (Siemens Trio, Erlangen, Germany). A T1 MPRAGE scan (TR/TE 2420/3.7&#x000a0;msec, 1&#x000a0;mm isotropic resolution, scan time 5&#x000bd;&#x000a0;min) was performed.</p></sec><sec id="brb3484-sec-0009"><title>Synthesis and purity of [<sup>11</sup>C]15&#x02010;4513</title><p>[<sup>11</sup>C]15&#x02010;4513 was synthesized by the adoption of the procedure of Halldin et&#x000a0;al. (<xref rid="brb3484-bib-0005" ref-type="ref">1992</xref>). Briefly, <sup>11</sup>CO<sub>2</sub>, either produced with the PET centers GE PETtrace or IBA18/18 cyclotron, was converted to [<sup>11</sup>C]methyl iodide applying a GE Healthcare MeI Microlab. [<sup>11</sup>C]methyl iodide was trapped at room temperature in a solution of 0.3&#x02013;0.5&#x000a0;mg Ro44&#x02010;3902 (ABX advanced biochemical compounds, Radeberg, Germany) in 0.3&#x000a0;mL DMF, containing 0.5&#x02013;1&#x000a0;mg NaH (60% dispersion in mineral oil; Sigma&#x02010;Aldrich A/S, Br&#x000f8;ndby, Denmark). After heating for 1&#x000a0;min at 50&#x000b0;C [<sup>11</sup>C]15&#x02010;4513 was isolated by preparative HPLC applying a 250&#x000a0;&#x000d7;&#x000a0;10&#x000a0;mm Phenomenex Luna C18(2) column and a mixture of 70&#x000a0;mmol/L NaH<sub>2</sub>PO<sub>4</sub> buffer and acetonitrile (70:30). The fraction containing [<sup>11</sup>C]15&#x02010;4513 was collected, diluted with 50&#x000a0;mL of sterile water. Afterward [<sup>11</sup>C]15&#x02010;4513 was trapped on Water Sep&#x02010;Pak A/S, Hedehusende, Denmark<sup>&#x000ae;</sup> C&#x02010;18 Plus light cartridge. Remaining acetonitrile was removed by flushing the Sep&#x02010;Pak cartridge with 20&#x000a0;mL of sterile water. [<sup>11</sup>C]15&#x02010;4513 was desorbed with 1&#x000a0;mL of sterile ethanol followed by 9&#x000a0;mL of saline. The final solution was sterile filtered via 0.22&#x02010;<italic>&#x003bc;</italic>m sterile filter into a sterile product vial. This procedure yielded 1&#x02013;6&#x000a0;GBq of [<sup>11</sup>C]15&#x02010;4513 within 35&#x000a0;min and radiochemical purities &#x0003e;95%. Amounts of nonradioactive [<sup>12</sup>C]15&#x02010;4513 were in the range 0.3&#x02013;3.5&#x000a0;<italic>&#x003bc;</italic>g/mL (1&#x02013;11&#x000a0;nmol/mL). Interestingly, we found increased radiolysis on the C&#x02010;18 Sep&#x02010;Pak affecting the radiochemical purity at very high radioactivities.</p></sec><sec id="brb3484-sec-0010"><title>Positron emission tomography</title><p>Participants were placed in the scanner with the orbitomeatal line parallel to the transaxial plane of the tomograph. Head position was monitored via laser crosshairs and video camera. In order to correct for attenuation of emitted radiation by skull and tissues, a transmission scan was acquired using a single rotating photon point source of 150&#x000a0;MBq of <sup>137</sup>Cs. Participants were pretreated with placebo or 100&#x000a0;mg <sc>l</sc>&#x02010;dopa + 25&#x000a0;mg carbidopa given orally to block peripheral metabolism of <sc>l</sc>&#x02010;dopa, thereby increasing tracer delivery to the brain. This was done 30&#x02013;45&#x000a0;min prior to injection of 400 (range 375&#x02013;425) MBq [<sup>11</sup>C]Ro15&#x02010;4513 through a cubital vein in 10&#x000a0;mL of normal saline over 30&#x000a0;sec. Three&#x02010;dimensional PET was recorded over 60&#x000a0;min, using an ECAT EXACT HR++ (CTI/Siemens 966; Siemens PET/CT Biograph, Erlangen, Germany) camera, which covers an axial field of view of 23.4&#x000a0;cm and provides 95 transaxial planes. The tomograph has a spatial resolution of 4.8&#x000a0;+&#x000a0;0.2&#x000a0;mm FWHM (transaxial, 1&#x000a0;cm off axis) and 5.6&#x000a0;mm&#x000a0;+&#x000a0;0.5&#x000a0;mm (axial, on axis) after image reconstruction. PET and MRI were coregistered to a common MR T1 atlas from Montreal Neurological Institute (MNI) (Collins et&#x000a0;al. <xref rid="brb3484-bib-0003" ref-type="ref">1998</xref>) using PMOD (PMOD Technologies Ltd., Zurich, Switzerland). The kinetic parameters of [<sup>11</sup>C]Ro15&#x02010;4513 were determined by the SRTM2 method using cerebellum as reference (Wu and Carson <xref rid="brb3484-bib-0025" ref-type="ref">2002</xref>). No FDR or cluster corrections were used as the regions were predefined.</p></sec></sec><sec id="brb3484-sec-0012"><title>Conflict of Interest</title><p>The authors declare no competing financial interest.</p></sec></body><back><ack id="brb3484-sec-0011"><title>Acknowledgments</title><p>The authors are grateful to Peter Parbo for help with PET scans, to Kim Mouridsen and Anne Nielsen for statistics, and to Henriette Vuust for help with figures. The study was supported by the Danish Research Council (research grant DFF&#x02010;1317&#x02010;00010).</p></ack><ref-list content-type="cited-references" id="brb3484-bibl-0001"><title>References</title><ref id="brb3484-bib-0001"><mixed-citation publication-type="journal" id="brb3484-cit-0001">
<string-name>
<surname>Assaf</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Jagannathan</surname>
</string-name>, <string-name>
<given-names>V. D.</given-names>
<surname>Calhoun</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Stevens</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Sahl</surname>
</string-name>, et&#x000a0;al. <year>2010</year>
<article-title>Abnormal functional connectivity of default mode sub&#x02010;networks in autism spectrum disorder patients</article-title>. <source>NeuroImage</source>
<volume>53</volume>:<fpage>247</fpage>&#x02013;<lpage>256</lpage>.<pub-id pub-id-type="pmid">20621638</pub-id></mixed-citation></ref><ref id="brb3484-bib-0002"><mixed-citation publication-type="journal" id="brb3484-cit-0002">
<string-name>
<surname>Castellanos</surname>, <given-names>F. X.</given-names>
</string-name>, <string-name>
<given-names>D. S.</given-names>
<surname>Margulies</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Kelly</surname>
</string-name>, <string-name>
<given-names>L. Q.</given-names>
<surname>Uddin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ghaffari</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kirsch Shaw</surname>
</string-name>, et&#x000a0;al. <year>2008</year>
<article-title>Cingulate&#x02010;precuneus interactions: a new locus of dysfunction in adult attention&#x02010;deficit/hyperactivity disorder</article-title>. <source>Biol. Psychiatry</source>
<volume>63</volume>:<fpage>332</fpage>&#x02013;<lpage>337</lpage>.<pub-id pub-id-type="pmid">17888409</pub-id></mixed-citation></ref><ref id="brb3484-bib-0003"><mixed-citation publication-type="journal" id="brb3484-cit-0003">
<string-name>
<surname>Collins</surname>, <given-names>D. J.</given-names>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Zijdenbos</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Kollokian</surname>
</string-name>, <string-name>
<given-names>J. G.</given-names>
<surname>Sled</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Kabani</surname>
</string-name>, <string-name>
<given-names>C. J.</given-names>
<surname>Holmes</surname>
</string-name>, and <string-name>
<given-names>A. C.</given-names>
<surname>Evans</surname>
</string-name>. <year>1998</year>
<article-title>Design and construction of a realistic digital brain phantom</article-title>. <source>IEEE Trans. Med. Imaging</source>
<volume>17</volume>:<fpage>463</fpage>&#x02013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">9735909</pub-id></mixed-citation></ref><ref id="brb3484-bib-0004"><mixed-citation publication-type="journal" id="brb3484-cit-0004">
<string-name>
<surname>Gallinat</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Winterer</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Herrmann</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Senkowski</surname>
</string-name>. <year>2004</year>
<article-title>Reduced oscillatory gamma&#x02010;band responses in unmedicated schizophrenic patients indicate impaired frontal network processing</article-title>. <source>Clin. Neurophysiol.</source>
<volume>115</volume>:<fpage>1863</fpage>&#x02013;<lpage>1874</lpage>.<pub-id pub-id-type="pmid">15261865</pub-id></mixed-citation></ref><ref id="brb3484-bib-0005"><mixed-citation publication-type="journal" id="brb3484-cit-0005">
<string-name>
<surname>Halldin</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Farde</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Litton</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Hall</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Sedvall</surname>
</string-name>. <year>1992</year>
<article-title>[<sup>11</sup>C]Ro&#x02010;15&#x02010;4513, a ligand for visualization of benzodiazepine receptor binding: preparation, autoradiography, and positron emission tomography</article-title>. <source>Psychopharmacology</source>
<volume>108</volume>:<fpage>16</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">1329130</pub-id></mixed-citation></ref><ref id="brb3484-bib-0006"><mixed-citation publication-type="journal" id="brb3484-cit-0006">
<string-name>
<surname>Ham</surname>, <given-names>T. E.</given-names>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Bonnelle</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hellyer</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jilka</surname>
</string-name>, <string-name>
<given-names>I. H.</given-names>
<surname>Robertson</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Leech</surname>
</string-name>, and <string-name>
<given-names>D.J.</given-names>
<surname>Sharp</surname>
</string-name>. <year>2014</year>
<article-title>The neural basis of impaired self&#x02010;awareness after traumatic brain injury</article-title>. <source>Brain</source>
<volume>137</volume>:<fpage>586</fpage>&#x02013;<lpage>597</lpage>.<pub-id pub-id-type="pmid">24371217</pub-id></mixed-citation></ref><ref id="brb3484-bib-0007"><mixed-citation publication-type="journal" id="brb3484-cit-0007">
<string-name>
<surname>Hoerbelt</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Lindsley</surname>
</string-name>, and <string-name>
<given-names>M. W.</given-names>
<surname>Fleck</surname>
</string-name>. <year>2015</year>
<article-title>Dopamine directly modulates GABAA receptors</article-title>. <source>J. Neurosci.</source>
<volume>35</volume>:<fpage>3525</fpage>&#x02013;<lpage>3536</lpage>.<pub-id pub-id-type="pmid">25716851</pub-id></mixed-citation></ref><ref id="brb3484-bib-0008"><mixed-citation publication-type="journal" id="brb3484-cit-0008">
<string-name>
<surname>Joensson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>K. R.</given-names>
<surname>Thomsen</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>Andersen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gross</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Mouridsen</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Sandberg</surname>
</string-name>, et al. <year>2015</year>
<article-title>Making sense: dopamine activates conscious self&#x02010;monitoring through medial prefrontal cortex</article-title>. <source>Hum. Brain Mapp.</source>
<volume>36</volume>:<fpage>1866</fpage>&#x02013;<lpage>1877</lpage>.<pub-id pub-id-type="pmid">25627861</pub-id></mixed-citation></ref><ref id="brb3484-bib-0009"><mixed-citation publication-type="journal" id="brb3484-cit-0009">
<string-name>
<surname>Keenan</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Nelson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>O'Connor</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Pascual Leone</surname>
</string-name>. <year>2001</year>
<article-title>Self&#x02010;recognition and the right hemisphere</article-title>. <source>Nature</source>
<volume>409</volume>:<fpage>305</fpage>.<pub-id pub-id-type="pmid">11201730</pub-id></mixed-citation></ref><ref id="brb3484-bib-0010"><mixed-citation publication-type="journal" id="brb3484-cit-0010">
<string-name>
<surname>Lew</surname>, <given-names>S. E.</given-names>
</string-name>, and <string-name>
<given-names>K. Y.</given-names>
<surname>Tseng</surname>
</string-name>. <year>2014</year>
<article-title>Dopamine modulation of GABAergic function enables network stability and input selectivity for sustaining working memory in a computational model of the prefrontal cortex</article-title>. <source>Neuropsychopharmacology</source>
<volume>39</volume>:<fpage>3067</fpage>&#x02013;<lpage>3076</lpage>.<pub-id pub-id-type="pmid">24975022</pub-id></mixed-citation></ref><ref id="brb3484-bib-0011"><mixed-citation publication-type="journal" id="brb3484-cit-0011">
<string-name>
<surname>Lingford&#x02010;Hughes</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Hume</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Feeney</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Hirani</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Osman</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Cunningham</surname>
</string-name>, et&#x000a0;al. <year>2002</year>
<article-title>Imaging the GABA&#x02010;benzodiazepine receptor subtype containing the alpha5&#x02010;subunit in&#x000a0;vivo with [11C]Ro15 4513 positron emission tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>22</volume>:<fpage>878</fpage>&#x02013;<lpage>889</lpage>.<pub-id pub-id-type="pmid">12142573</pub-id></mixed-citation></ref><ref id="brb3484-bib-0012"><mixed-citation publication-type="journal" id="brb3484-cit-0012">
<string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Duan</surname>
</string-name>, <string-name>
<given-names>A. F.</given-names>
<surname>Alexander&#x02010;Bloch</surname>
</string-name>, et&#x000a0;al. <year>2014</year>
<article-title>Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease</article-title>. <source>Cereb. Cortex</source>
<volume>24</volume>:<fpage>1422</fpage>&#x02013;<lpage>1435</lpage>.<pub-id pub-id-type="pmid">23314940</pub-id></mixed-citation></ref><ref id="brb3484-bib-0013"><mixed-citation publication-type="journal" id="brb3484-cit-0013">
<string-name>
<surname>Lou</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Luber</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Crupain</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Keenan</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Nowak</surname>
</string-name>, <string-name>
<given-names>T. W.</given-names>
<surname>Kjaer</surname>
</string-name>, et al. <year>2004</year>
<article-title>Parietal cortex and representation of the mental Self</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>101</volume>:<fpage>6827</fpage>&#x02013;<lpage>6832</lpage>.<pub-id pub-id-type="pmid">15096584</pub-id></mixed-citation></ref><ref id="brb3484-bib-0014"><mixed-citation publication-type="journal" id="brb3484-cit-0014">
<string-name>
<surname>Lou</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Skewes</surname>
</string-name>, <string-name>
<given-names>K. R.</given-names>
<surname>Thomsen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Overgaard</surname>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lau</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Mouridsen</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Roepstorff</surname>
</string-name>. <year>2011</year>
<article-title>Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words</article-title>. <source>J. Vis.</source>
<volume>11</volume>:<fpage>1</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="brb3484-bib-0015"><mixed-citation publication-type="journal" id="brb3484-cit-0015">
<string-name>
<surname>Luber</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Keenan</surname>
</string-name>, and <string-name>
<given-names>S. H.</given-names>
<surname>Lisanby</surname>
</string-name>. <year>2012</year>
<article-title>Self&#x02010;enhancement processing in the default network: a single&#x02010;pulse TMS study</article-title>. <source>Exp. Brain Res.</source>
<volume>223</volume>:<fpage>177</fpage>&#x02013;<lpage>187</lpage>.<pub-id pub-id-type="pmid">22965551</pub-id></mixed-citation></ref><ref id="brb3484-bib-0016"><mixed-citation publication-type="journal" id="brb3484-cit-0016">
<string-name>
<surname>Ransom</surname>, <given-names>C. B.</given-names>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Tao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>W. J.</given-names>
<surname>Spain</surname>
</string-name>, and <string-name>
<given-names>G. B.</given-names>
<surname>Richerson</surname>
</string-name>. <year>2013</year>
<article-title>Rapid regulation of tonic GABA currents in cultured rat hippocampal neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>109</volume>:<fpage>803</fpage>&#x02013;<lpage>812</lpage>.<pub-id pub-id-type="pmid">23114210</pub-id></mixed-citation></ref><ref id="brb3484-bib-0017"><mixed-citation publication-type="journal" id="brb3484-cit-0017">
<string-name>
<surname>R&#x000f8;mer Thomsen</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Joensson</surname>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>M&#x000f8;ller</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gross</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Kringelbach</surname>
</string-name>, and <string-name>
<given-names>J.P.</given-names>
<surname>Changeux</surname>
</string-name>. <year>2013</year>
<article-title>Altered paralimbic interaction in behavioral addiction</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>110</volume>:<fpage>4744</fpage>&#x02013;<lpage>4749</lpage>.<pub-id pub-id-type="pmid">23487797</pub-id></mixed-citation></ref><ref id="brb3484-bib-0018"><mixed-citation publication-type="journal" id="brb3484-cit-0018">
<string-name>
<surname>Romo&#x02010;Parra</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Aceves</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Guti&#x000e8;res</surname>
</string-name>. <year>2005</year>
<article-title>Tonic modulation inhibition by dopamine D4 receptors in rat hippocampus</article-title>. <source>Hippocampus</source>
<volume>15</volume>:<fpage>254</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">15476261</pub-id></mixed-citation></ref><ref id="brb3484-bib-0019"><mixed-citation publication-type="journal" id="brb3484-cit-0019">
<string-name>
<surname>Semyano</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Walker</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Kullmann</surname>
</string-name>, and <string-name>
<given-names>R. A.</given-names>
<surname>Silver</surname>
</string-name>. <year>2004</year>
<article-title>Tonically active GABA A receptors: modulating gain and maintaining the tone</article-title>. <source>Trends Neurosci.</source>
<volume>27</volume>:<fpage>262</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">15111008</pub-id></mixed-citation></ref><ref id="brb3484-bib-0020"><mixed-citation publication-type="journal" id="brb3484-cit-0020">
<string-name>
<surname>Sesack</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<given-names>D. B.</given-names>
<surname>Carr</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Omelchenko</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Pinto</surname>
</string-name>. <year>2003</year>
<article-title>Anatomical substrates for glutamate&#x02010;dopamine interactions</article-title>. <source>Ann. N. Y. Acad. Sci.</source>
<volume>1003</volume>:<fpage>36</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">14684434</pub-id></mixed-citation></ref><ref id="brb3484-bib-0021"><mixed-citation publication-type="journal" id="brb3484-cit-0021">
<string-name>
<surname>Sohal</surname>, <given-names>V. S.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Yizhar</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Deisseroth</surname>
</string-name>. <year>2009</year>
<article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance</article-title>. <source>Nature</source>
<volume>459</volume>:<fpage>698</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">19396159</pub-id></mixed-citation></ref><ref id="brb3484-bib-0022"><mixed-citation publication-type="journal" id="brb3484-cit-0022">
<string-name>
<surname>Stokes</surname>, <given-names>P. R.</given-names>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Myers</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Kalk</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Watson</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Erritzoe</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Wilson</surname>
</string-name>, et&#x000a0;al. <year>2014</year>
<article-title>Acute increases in synaptic GABA detectable in the living human brain: a [11C]Ro15&#x02010;4513 study</article-title>. <source>NeuroImage</source>
<volume>99</volume>:<fpage>158</fpage>&#x02013;<lpage>165</lpage>.<pub-id pub-id-type="pmid">24844747</pub-id></mixed-citation></ref><ref id="brb3484-bib-0023"><mixed-citation publication-type="journal" id="brb3484-cit-0023">
<string-name>
<surname>Tomasi</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>G. J.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>N. D.</given-names>
<surname>Volkow</surname>
</string-name>. <year>2013</year>
<article-title>Energetic cost of brain functional connectivity</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>1010</volume>:<fpage>13642</fpage>&#x02013;<lpage>13647</lpage>.<pub-id pub-id-type="pmid">23898179</pub-id></mixed-citation></ref><ref id="brb3484-bib-0024"><mixed-citation publication-type="journal" id="brb3484-cit-0024">
<string-name>
<surname>Voss</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Holzmann</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hobson</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Paulus</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Koppehele&#x02010;Gossel</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Klimke</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Nitsche</surname>
</string-name>. <year>2014</year>
<article-title>Induction of self awareness in dreams through frontal low current stimulation of gamma activity</article-title>. <source>Nat. Neurosci.</source>
<volume>17</volume>:<fpage>810</fpage>&#x02013;<lpage>812</lpage>.<pub-id pub-id-type="pmid">24816141</pub-id></mixed-citation></ref><ref id="brb3484-bib-0025"><mixed-citation publication-type="journal" id="brb3484-cit-0025">
<string-name>
<surname>Wu</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<given-names>R. E.</given-names>
<surname>Carson</surname>
</string-name>. <year>2002</year>
<article-title>Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>22</volume>:<fpage>1440</fpage>&#x02013;<lpage>1452</lpage>.<pub-id pub-id-type="pmid">12468889</pub-id></mixed-citation></ref></ref-list></back></article>